Navigation Links
New fertility drug development techniques by Organon

In the 7th International Symposium on GnRH Analogs in Cancer and Human Reproduction, Organon presented new techniques of development of fertility drugs. Organon scientists have succeeded in customizing the follicle-stimulating hormone(FSH) molecule by adding a hybrid subunit, which extends FSH's active life. This was achieved through an international collaboration. This longer active life will mean fewer injections for the infertile patient, making the treatment less difficult// and more patient-friendly. The company indicated that a long-acting form of the genetically-produced fertility drug, Puregon(rFSH), has moved into the dose-finding phase of its development using the latest techniques of "knowledge driven drug development" (KD3). These new techniques model the drug's underlying mechanisms, and use that information to support decisions about doses, dose regimens and design of future trials.

Organon is also in the process of developing oral tablet formulation alternative to the injectable hormone hCG (human chorionic gonadotropin). hCG has been used, in the past 30 years, to make ovulation and final oocyte maturation take place with precise timing. However, it has only been available in the injectable form due to its high molecular weight. Now, scientists have identified through high-throughput screening, compounds similar to hCG, but with lower molecular weight. These compounds have been optimized with respect to potency, selectivity and safety. The new compound, an LH/hCG agonistic agent, interacts with the human LH receptor just like LH (and hCG). Scientists carried out pre-clinical tests of this LH agonist in rats and found that it induced ovulation after a single oral dose and that fertilization of the ovulated eggs resulted in the normal implantation of healthy embryos in these rats. The scientists at Organon who are also exploring the IVF cycle concluded that this oral compound could also play a role in other infertility indications or at othe
'"/>




Page: 1 2

Related medicine news :

1. Male infertility in relation to cancer
2. Male infertility in relation to pesticide
3. Infertility in relation with virus
4. Shapely sperm-a valuable indicator of fertility
5. Relief to pregnant women using fertility drugs
6. How to repeal male infertility?
7. Benefits in fertility procedures
8. Endometriosis connected to fertility
9. Mountain biking connected to infertility
10. Reduced fertility in men who mountain bike
11. Infertility may result from bone fragments

Post Your Comments:
(Date:11/26/2009)...er thrill when on an emotional rollercoaster, stud... News) -- Call it the fear factor meets the jubila...tators -- especially those who root for the winnin...a closely contested match and victory was in doubt..., Chew on that this Thanksgiving weekend as you,r...
(Date:11/26/2009)... Benton Communications announces a highl...tem for retailers struggling to make an economic r...er 26, 2009 -- Flu fears is the type of challenge ...ncy room, according to Dr. David Benton, business ...iness growth system – The Rfactor Intensive...
(Date:11/25/2009)...LLE,Calif.,Nov.25/PRNewswire-FirstCall/-- OnyxPha...thecompanywillhosttwoinvestoreventsinDecember: ,...CT/10:00a.m.ET ,, Principalinvestigatorswilld...apsedand/orrefractorymultiplemyeloma,asfeaturedatt...gandExpositioninNewOrleans,LA.Theteleconferencewil...
(Date:11/25/2009)...PRING,Md.,Nov.25/PRNewswire-USNewswire/--Anarticle...ugEvaluationandResearch,titled"ADifficultBalance-P...v.26,2009issueofTheNewEnglandJournalofMedicine. ,...90824/FDALOGO ) ,, Inthearticle,Woodcockdiscuss...icationforthosewhoneeditandmanagingtherisksposedby...
(Date:11/25/2009)...vivors of testicular cancer who were treated with ...effects, including neurological side effects and R...ed with chemotherapy, according to a new study pub...ational Cancer Institute . , Marianne Brydy, M.D...sity Hospital, in Bergen, Norway, and colleagues c...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...Someday, DNA tests might spot those most at risk, ...Day News) -- Variations in two genes may help spur...y prescribed antidepressant, research suggests. , ...but dangerous side effect. , "These findings, if ...
...WARSAW, Ind., Sept. 27 As part of an industry-wid... manufacturers, DePuy,Orthopaedics, Inc. has enter...ey,s Office that resolves a previously reported go...istrict,of New Jersey. The agreement contains no ...
...BEDFORD, Mass., Sept. 27 Insulet Corporation,(Nas...Management System,today announced that it has been...om the Community Health Accreditation Program (CHA...g the quality of home and community-based health c...
...RESEARCH TRIANGLE PARK, N.C., Sept. 27 North Caro...optometry degree are,encouraged to attend the 2007... sponsored by the N.C. State Education Assistance ...ctober 8, 2007 North Carolina State University in ...
...Co-Chairs Are Reps. Berry, Moran, McMorris Rodgers...onal,Community Pharmacists Association (NCPA) toda...ongressional Community Pharmacy Coalition. The,Coa...alues these small business owners who often reside...
...Parents, confident children are protected when sho...ills 99%+ of bacteria on shopping carts, GREEN BA...Wis., is proud to be an iParenting Media Award Win...l were put,through the only internationally certif...
Other Medicine News:Health News:Genes Might Predispose Antidepressant Users to Suicidal Thoughts 2Health News:Genes Might Predispose Antidepressant Users to Suicidal Thoughts 3Health News:Statement of DePuy Orthopaedics, Inc. Regarding Agreement with U.S. Attorney's Office 2Health News:Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program 2Health News:Optometry Career Conferences Set for Five N.C. Campuses in October 2Health News:Congressional Community Pharmacy Coalition To Protect Community Pharmacies and Preserve Patient Access 2Health News:Congressional Community Pharmacy Coalition To Protect Community Pharmacies and Preserve Patient Access 3Health News:PureCart Systems of Green Bay, Wis., is an Honored Recipient of an iParenting Media Award 2
(Date:11/25/2009)...irstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedicalde...disruptivesurgicaltreatmentsforthespine,announcedt...30,2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecallw...heCompany,sproductsandwillincludecommentsfrommanag...ial-innumbersare1-877-407-4018fordomesticcallersan...
(Date:11/25/2009)...Reportlinker.comannouncesthatanewmarketresearchrep...gDelivery-USMarketTrends&Analysis http://www....---US-Market-Trends--Analysis.html ,, TheUSint...therapeuticapplicationsfromthedeliveryofconvention...apeuticdrugs.Thefutureofthetechnologyhingesontothe...
(Date:11/25/2009)...RNewswire/-- ChemoCentryx,Inc.,announcedtodaythat...heProspectiveRandomizedOralTherapyEvaluationinCroh...ntswithmoderate-to-severeCrohn,sdiseasedemonstrate...typrofile.Thestudydemonstratedevidenceofclinicalef...0-pointdecreaseintheCrohn,sDiseaseActivityIndex(CD...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Tasty Foods Send Signal to Brain to Keep Eating 57329 1Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician 14087 1Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician 14087 2Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician 14087 3Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician 14087 4Breast Health and Healing Foundation Convenes Groundbreaking Breast Cancer Summit in Washington D C On October 9 2009 57327 1Breast Health and Healing Foundation Convenes Groundbreaking Breast Cancer Summit in Washington D C On October 9 2009 57327 2Breast Health and Healing Foundation Convenes Groundbreaking Breast Cancer Summit in Washington D C On October 9 2009 57327 3
...Thallion Pharmaceuticals Inc.,(TSX: TLN) announced...linical trial investigating ECO-4601 in advanced c...art of the American,Society of Clinical Oncology (...Phase I dose escalation portion of the study, 14,p... and one,glioma), that had completed and not respo...
...hich compares favorably with,the activity of mTOR ...wire-FirstCall/ - AEterna,Zentaris Inc. , a global...erapy and oncology, today announced that its partn...tlining Phase 1 and,Phase 2 results for perifosine...r compound, for the treatment of patients with,adv...
Other Medicine Technology:Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 2Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 3AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 2AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 3AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 4
...; Oxygen flowmeter with a Lexan®inner calibrat...bration and manufacturing defects. A wide range of...Also available with all popular inlet connections,... configurations. Our extra large knob coupled with...
...he entire series of time-tested Timeter® Class...ge of the needs of care providers and patients ali... in the craftsmanship. You can see it in the perfo...c Flowmeter is hand-crafted and engineered to the ...
Soft-Touch Timeter® 15 LPM Dual Oxygen Flowmeter w/T Bar & 2 Power Take Off
Soft-Touch Timeter® 15 LPM Dual Oxygen Flowmeter w/Y Bar & 1 Power Take Off
Medicine Products: